|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cao Y and Wang X: Effects of molecular
markers on the treatment decision and prognosis of colorectal
cancer: A narrative review. J Gastrointest Oncol. 12:1191–1196.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen G, Peng J, Xiao Q, Wu HX, Wu X, Wang
F, Li L, Ding P, Zhao Q, Li Y, et al: Postoperative circulating
tumor DNA as markers of recurrence risk in stages II to III
colorectal cancer. J Hematol Oncol. 14(80)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang Q, Tey J, Yang Z, Li P, Peng L, Fu
S, Huang G, Xiong F and Lu JJ: Adjuvant chemoradiation plus
intraoperative radiotherapy versus adjuvant chemoradiation alone in
patients with locally advanced rectal cancer. Am J Clin Oncol.
38:11–16. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim DD, Litow KJ, Lumbra TJ and Masri MM:
Failure of 3 different methods and biopsy sites to diagnose a
patient with invasive colorectal cancer: A case report. Medicine
(Baltimore). 98(e15656)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brown G, Drury AE, Cunningham D and
Husband JE: CT detection of hydronephrosis in resected colorectal
cancer: A predictor of recurrent disease. Clin Radiol. 58:137–142.
2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Larsen SG, Wiig JN and Giercksky KE:
Hydronephrosis as a prognostic factor in pelvic recurrence from
rectal and colon carcinomas. Am J Surg. 190:55–60. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sugimoto H, Oda G, Yokoyama M, Hayashi K,
Yoshino M, Ogawa A, Hosoya T, Nakagawa T and Uetake H:
Hydronephrosis caused by metastatic breast cancer. Case Rep Oncol.
14:378–385. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Duan XH, Li FY, Han XW, Wu G, Zhang JH,
Tian YD and Zhang YC: Clinical observation of double percutaneous
nephrostomy combined with ureter occlusion stent for treating
cervical cancer complicated with vesicovaginal fistula. Cancer
Biother Radiopharm: Oct 5, 2020 (Epub ahead of print).
|
|
10
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McNamara DA, Fitzpatrick JM and O'Connell
PR: Urinary tract involvement by colorectal cancer. Dis Colon
Rectum. 46:1266–1276. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ghanem AI, Glide-Hurst C, Siddiqui MS,
Chetty IJ and Movsas B: Retroperitoneal metastasis abutting small
bowel: A novel magnetic resonance-guided radiation approach.
Cureus. 10(e2412)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aghalarov I, Forster S, Tannapfel A, Ubrig
B, Uhl W and Belyaev O: A double metachronous ureter metastasis
following curative resection of rectal cancer. Case Rep
Gastroenterol. 15:450–455. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sato T, Sakai H, Goto Y, Kojima S, Nomura
Y, Nakayama G, Hirakawa Y, Mikagi K, Kawahara R, Ishikawa H, et al:
A case of laparoscopic hepatectomy and combined resection of lymph
nodes and ureter for liver metastasis after colorectal cancer
surgery, with local lymph node recurrence and bilateral
hydronephrosis. Gan To Kagaku Ryoho. 46:751–753. 2019.PubMed/NCBI(In Japanese).
|
|
15
|
Lev-Chelouche D, Keidar A, Rub R, Matzkin
H and Gutman M: Hydronephrosis associated with colorectal
carcinoma: Treatment and outcome. Eur J Surg Oncol. 27:482–486.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cheng C, Rodriguez-Bigas MA and Petrelli
N: Is there a role for curative surgery for pelvic recurrence from
rectal carcinoma in the presence of hydronephrosis? Am J Surg.
182:274–277. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hamanaka M, Noda M, Imada A, Song J,
Kimura K, Babaya A, Kobayashi M, Tsukamoto K, Takaki H, Yamano T,
et al: Two cases of CT-guided radiofrequency ablation therapy for
pelvic recurrence from rectal cancer. Gan To Kagaku Ryoho.
45:1794–1796. 2018.PubMed/NCBI(In Japanese).
|
|
18
|
Yoshitomi M, Hashida H, Nomura A, Ueda S,
Terajima H and Osaki N: A case of locally advanced sigmoid colon
cancer treated with neoadjuvant chemoradiotherapy. Gan To Kagaku
Ryoho. 41:1175–1178. 2014.PubMed/NCBI(In Japanese).
|
|
19
|
Kagawa Y, Kato T, Naito A, Murakami K,
Katsura Y, Ohmura Y, Okishiro M, Takeno A, Egawa C, Takeda Y and
Tamura S: A case of consciousness disturbance caused by
hyperammonemia during a mFOLFOX6 regimen for metastatic colon
cancer. Gan To Kagaku Ryoho. 42:2160–2162. 2015.PubMed/NCBI(In Japanese).
|
|
20
|
Sakisaka H, Kato T, Kagawa Y, Ishida T,
Sato Y, Morimoto Y, Matsushita K, Hashimoto T, Kusama H, Kimura K,
et al: Cetuximab improved the poor performance status of a
colorectal cancer patient. Gan To Kagaku Ryoho. 41:1776–1778.
2014.PubMed/NCBI(In Japanese).
|
|
21
|
Kuwabara H, Yamamoto Y, Baba H, Mitsuoka
A, Nakamura H, Sanada T, Baba H, Goseki N, Hodotsuka M and Sano T:
A patient with unresectable progressive advanced rectal cancer
maintained in a state of remission by using combination therapy.
Gan To Kagaku Ryoho. 39:1929–1931. 2012.PubMed/NCBI(In Japanese).
|
|
22
|
Aderka D, Stintzing S and Heinemann V:
Explaining the unexplainable: Discrepancies in results from the
CALGB/SWOG 80405 and FIRE-3 studies. Lancet Oncol. 20:e274–e283.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xiong L, Lou Y and Wang L: Effect of
bevacizumab combined with first-line chemotherapy on metastatic
colorectal cancer. Am J Transl Res. 13:3609–3617. 2021.PubMed/NCBI
|
|
24
|
Westberg K, Palmer G, Hjern F, Nordenvall
C, Johansson H, Holm T and Martling A: Population-based study of
factors predicting treatment intention in patients with locally
recurrent rectal cancer. Br J Surg. 104:1866–1873. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Henry LR, Sigurdson E, Ross E and Hoffman
JP: Hydronephrosis does not preclude curative resection of pelvic
recurrences after colorectal surgery. Ann Surg Oncol. 12:786–792.
2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tanaka T, Yanase M and Takatsuka K:
Clinical course in patients with percutaneous nephrostomy for
hydronephrosis associated with advanced cancer. Hinyokika Kiyo.
50:457–462. 2004.PubMed/NCBI
|
|
27
|
Haas CR, Shah O and Hyams ES: Temporal
trends and practice patterns for inpatient management of malignant
extrinsic ureteral obstruction in the United States. J Endourol.
34:828–835. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Atar A, Oktar T, Kucukgergin C, Kalelioglu
I, Seckin S, Ander H, Ziylan O and Kadioglu TC: The roles of serum
and urinary carbohydrate antigen 19-9 in the management of patients
with antenatal hydronephrosis. J Pediatr Urol. 11:133.e1–5.
2015.PubMed/NCBI View Article : Google Scholar
|
